Cardiology
Study Finds Prasugrel May Offer Better Outcomes Than Ticagrelor for Diabetic Patients With Stents
New research presented at the American Heart Association's Scientific Sessions 2025 suggests prasugrel may be more effective than ticagrelor at preventing heart attacks, strokes, bleeding complications and death in diabetic patients who received coronary stents, challenging current interchangeable use of these antiplatelet medications.
Tailored Vitamin D Doses Reduce Heart Attack Risk by 52% in Heart Disease Patients
Adults with heart disease who received personalized vitamin D supplementation to achieve optimal blood levels experienced more than half the risk of heart attack compared to those without vitamin D monitoring, according to preliminary research presented at the American Heart Association's Scientific Sessions 2025.
Daily Coffee Consumption Linked to Reduced AFib Recurrence in New Clinical Trial
A new clinical trial reveals that adults with atrial fibrillation who drank one cup of coffee daily were 39% less likely to experience recurrent AFib episodes, challenging conventional medical advice about caffeine avoidance for heart rhythm patients.
Earlier Blood Transfusions May Reduce Heart Failure Risk in Cardiac Patients After Surgery
A new study suggests that transfusing blood earlier in patients with heart disease undergoing major surgery may significantly reduce the risk of heart failure and irregular heartbeat without increasing severe complication rates.
Catheter Ablation May Eliminate Need for Blood Thinners in Some AFib Patients, Study Finds
New research suggests successful catheter ablation for atrial fibrillation reduces stroke risk enough that many patients can safely discontinue potent blood thinners in favor of aspirin, potentially reducing bleeding complications while maintaining stroke protection.
Shorter Clot-Prevention Therapy After Stent Placement Proves Effective for AFib Patients
New research shows a one-month course of dual clot-preventing therapy followed by single medication treatment is as effective as year-long dual therapy for preventing stroke, heart attack and death in atrial fibrillation patients with stents, while significantly reducing bleeding complications.
Standard Medical Care Outperforms Minimally Invasive Procedure for High-Risk Atrial Fibrillation Patients
New research presented at the American Heart Association's Scientific Sessions 2025 found that standard medical care, including blood thinners when appropriate, proved more effective than a catheter-based procedure for preventing stroke and other complications in older atrial fibrillation patients at high risk of bleeding and stroke.
HeartBeam Submits Breakthrough ECG Technology for FDA Clearance
HeartBeam Inc. has submitted its innovative 12-lead ECG synthesis software to the FDA for clearance, representing a significant advancement in cardiac arrhythmia detection and management.
HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst
HeartBeam Inc. received a Buy rating and $4 price target from Roth Capital, which emphasized the company's potential FDA clearance for its 12-lead ECG synthesis software and its position to transform remote cardiac monitoring.
American Heart Association Launches Initiative to Accelerate Aortic Stenosis Diagnosis and Clinical Trial Access
The American Heart Association has launched a new initiative to improve early diagnosis of aortic stenosis and increase participation in clinical trials, potentially transforming care for this serious heart condition that often goes undiagnosed until advanced stages.
Hidden Atrial Dysfunction Identified as Stroke Risk Factor in Heart Muscle Disease Patients
A new study reveals that people with transthyretin amyloid cardiomyopathy face significantly higher stroke risk when they have atrial electromechanical dysfunction, and researchers have developed a noninvasive assessment tool to identify those who might benefit from preventive treatments.
Combined Biomarker Analysis Reveals Triple Heart Attack Risk in High-Risk Individuals
A new study shows that analyzing three specific biomarkers together can identify individuals with nearly triple the risk of heart attack, potentially enabling earlier intervention and personalized prevention strategies.
AI Tool Detects Structural Heart Disease Using Smartwatch ECG Sensors
An artificial intelligence algorithm paired with smartwatch ECG sensors can accurately detect structural heart diseases, potentially making early screening more accessible to millions of people who already own these devices.
HeartBeam to Discuss Q3 2025 Results and Regulatory Progress in November Conference Call
HeartBeam will host a conference call on November 13, 2025, to discuss third-quarter results and provide updates on its FDA-cleared 3D ECG technology that could transform remote cardiac monitoring.
HeartBeam Partners With HeartNexus to Expand Remote Cardiac Monitoring Services
HeartBeam's partnership with HeartNexus enables 24/7 remote cardiology services and real-time ECG interpretation, expanding access to medical-grade cardiac care outside traditional healthcare facilities.
American Heart Association Launches Digital Health Certification to Standardize Cardiac Telemedicine
The American Heart Association has introduced a new professional certification program to standardize digital health training for cardiac care providers as telehealth adoption expands rapidly.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care with Medical-Grade Accuracy
HeartBeam is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into synthesized 12-lead ECGs, potentially enabling earlier detection of heart rhythm problems and reducing hospitalizations through accessible, patient-centered cardiac monitoring.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care Delivery
HeartBeam Inc. is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into full 12-lead ECGs, potentially enabling earlier detection and treatment of heart conditions outside medical facilities.
NFL Players Lead National CPR Awareness Campaign on World Restart a Heart Day
The American Heart Association and NFL have launched the 2025 Nation of Lifesavers initiative with 30 player ambassadors to address the critical need for CPR education, as immediate intervention can double or triple survival rates for sudden cardiac arrest victims.
UT Southwestern Cardiologist Amit Khera Receives Prestigious 2025 Chairman's Award from American Heart Association
Dr. Amit Khera's recognition highlights his transformative contributions to preventive cardiology, including developing NASA's astronaut heart risk calculator and advancing cardiovascular disease prevention through innovative research and leadership.
HeartBeam Validates Portable ECG Technology in Pivotal Study
HeartBeam's portable ECG device demonstrates strong correlation with traditional 12-lead ECGs in clinical study, potentially revolutionizing remote cardiac monitoring for heart rhythm problems.
NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research
Dr. Judith Hochman's recognition by the American Heart Association highlights her pivotal clinical trials that have reshaped global cardiology guidelines and improved patient outcomes in ischemic heart disease.
HeartBeam's Portable ECG System Aims to Transform Remote Cardiac Monitoring
HeartBeam is developing the first cable-free 12-lead ECG system that enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing how patients monitor heart health remotely.
HeartBeam's Portable ECG System Aims to Transform Cardiac Care Accessibility
HeartBeam Inc. is developing a credit card-sized, cable-free ECG system that enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing remote cardiac monitoring.
HeartBeam's Cable-Free ECG System Enables Multi-Angle Cardiac Monitoring for At-Home Arrhythmia Detection
HeartBeam Inc.'s FDA-cleared cable-free ECG device captures heart signals from three distinct directions, potentially improving diagnostic precision for arrhythmias and enabling timely at-home cardiac monitoring.
Psychological Distress After Heart Attack Linked to Increased Risk of Future Cardiac Events
New research reveals that psychological distress affects up to 50% of heart attack survivors and increases the risk of future cardiac events by 1.3 to 2 times, highlighting the critical need for integrated mental health care in cardiac recovery.
HeartBeam Nears FDA Clearance for Revolutionary ECG Technology Set to Transform Cardiac Monitoring
HeartBeam is preparing for the commercial launch of its innovative 12-lead ECG synthesis software, which could significantly improve arrhythmia detection in both clinical and home settings pending FDA clearance expected by year-end.
HeartBeam Advances Revolutionary ECG Technology Toward FDA Clearance and Commercial Launch
HeartBeam Inc. is preparing for the commercial launch of its innovative 12-lead ECG synthesis software for arrhythmia assessment, which could transform cardiac diagnostics in both clinical and home settings pending FDA clearance expected by year-end.
HeartBeam Develops First Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring
HeartBeam Inc. is advancing cardiac care with its innovative cable-free ECG system that enables comprehensive arrhythmia assessment outside clinical settings, addressing limitations of traditional ECG technology.
HeartBeam Study Shows Comparable Accuracy to Standard ECG in Arrhythmia Detection
HeartBeam's 3D ECG system demonstrates comparable accuracy to standard 12-lead ECGs in detecting arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.